Patients appear to be at higher risk of heart problems or stroke when prescriptions for the newest cholesterol-lowering drugs are rejected by insurance companies or unfilled by patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
source https://www.lifetechnology.com/blogs/life-technology-news-blog/rejected-and-unfilled-prescriptions-for-new-more-expensive-cholesterol-drugs-tied-to-higher-heart-stroke-risk